查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1520620

多重檢測的全球市場的評估:各產品，各類型，各技術，各用途，各終端用戶，各地區，機會，預測，2017年～2031年

Multiplex Assays Market Assessment, By Product, By Type, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 231 Pages | 商品交期: 3-5個工作天內

價格
根據預測，全球多重檢測市場規模將從 2023 年的 31.9 億美元成長到 2031 年的 69.2 億美元，2024-2031 年預測期間複合年增長率為 10.16%。自體免疫疾病、慢性病和傳染病的日益普及、藥物開發和發現投資的增加以及多重檢測應用的擴大推動了市場擴張。自體抗體的檢測對於癌症、自體免疫疾病、細胞激素和傳染病研究至關重要，多重分析可幫助研究人員從一個樣本中測量多種自體抗體，從而提高時間效率。因此，臨床和生命科學應用對多重檢測的需求不斷增加。

世界各地癌症患者數量的不斷增加正在推動全球多重檢測市場的需求。美國國家癌症研究所估計，2024 年美國將診斷出 2,001,140 名新癌症患者。使用 Luminex 技術進行基於循環癌症生物標記微珠的多重測定，可以同時分析多種腫瘤類型中的多種癌症生物標記。它還有助於推進免疫腫瘤學、肺癌和乳癌研究。分離的蛋白質生物標記的檢測通常不足以區分腫瘤與非腫瘤。借助多重分析對循環和細胞內癌症標記進行多重檢測可以加速與致瘤過程和正常穩態相關的研究。

對藥物開發和藥物發現的日益關注是推動多重檢測全球市場規模的關鍵因素之一。藥物發現幫助製藥業確定有助於治療疾病的分子實體。藥物開發過程中涉及的各個步驟有助於評估與藥物相關的安全性、有效性和各種風險。這就是為什麼公司積極投資開發解決方案，以加快藥物開發和藥物發現所需的各個步驟。

本報告提供全球多重檢測市場相關調查，提供市場概要，以及各產品，各類型，各技術，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 調查手法

第2章 計劃的範圍和定義

第3章 摘要整理

第4章 全球多重檢測市場預測，2017年～2031年

  • 市場規模與預測
  • 各產品
  • 各類型
  • 各技術
  • 各用途
  • 各終端用戶
  • 各地區
  • 各企業市場佔有率(%)、2023年

第5章 全球多重檢測市場預測(各地區，2017年～2031年)

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 市場製圖，2023年

第7章 宏觀環境和產業結構

  • 供給需求分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL分析
  • 波特的五力分析

第8章 市場動態

第9章 法規結構和革新

第10章 主要加入企業的形勢

第11章 價格分析

第12章 案例研究

第13章 主要加入企業預測

  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • DiaSorin S.p.A.
  • Seegene, Inc.
  • Abcam Limited
  • MESO SCALE DIAGNOSTICS, LLC
  • Merck KGaA

第14章 策略性建議

第15章 諮詢方式和免責聲明

Product Code: MX11642

Global multiplex assays market is projected to witness a CAGR of 10.16% during the forecast period 2024-2031, growing from USD 3.19 billion in 2023 to USD 6.92 billion in 2031. The market's expansion is boosted by the increasing prevalence of autoimmune, chronic, and infectious diseases, rising investments towards drug development and discovery, and growing applications of multiplex assays. Detection of autoantibodies is essential in cancer, autoimmune, cytokine, and infectious disease research and multiplex analysis aids researchers in measuring several autoantibodies from one sample, increasing time efficiency. Thus, propelling the requirement for multiplex assays for clinical and life science applications.

The increasing cases of cancer in various regions across the globe are propelling the global multiplex assays market demand. As per the estimates of the National Cancer Institute, 2,001,140 new cases of cancer are expected to be diagnosed in the United States in 2024. Circulating cancer biomarker bead-based multiplex assays that use Luminex technology allow the simultaneous analysis of multiple oncology biomarkers in several types of tumors. They are also aiding in supporting advancements in immune-oncology, lung cancer, and breast cancer research. Detecting isolated protein biomarkers is not often sufficient for distinguishing non-tumor from tumor, the deployment of multiplexed detection of circulating and intracellular cancer markers with the help of multiplex assays can boost the acceleration of studies related to tumorigenic processes and normal homeostasis.

Rising Autoimmune Cases Boost Market Demand

The rising cases of autoimmune diseases are positively influencing the growth of the market as multiplex autoantibody assays are capable of detecting several autoantibodies that are present in a wide range of patients with systemic autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus, in one run. According to estimates from the Johns Hopkins Medicine, autoimmune diseases affect approximately 3% of the population of the United States. The correct interpretation and usage of serological testing for providing a diagnosis of autoimmune disease presents various challenges because of the specificity and sensitivity of tests that are used for detecting autoimmune diseases and the provision of different results by techniques such as MBAA and indirect immunofluorescence that are used for detecting autoantibodies. Multiplex immunoassays also provide a wide range of advantages, including the ability to deliver more information from the sample in a time-efficient manner.

Increasing Investments in Drug Development Boost Market Growth

The rising emphasis towards drug development and discovery is one of the major factors boosting the global multiplex assays market size. Drug discovery aids the pharmaceutical sector in determining the molecular entities that can be beneficial in treating diseases. The various steps associated with the drug development process aid in assessing the safety, efficacy, and the various risks associated with the drugs. Thus, various companies actively invest in the development of solutions that are capable of increasing the speed of the different steps essential in drug development and discovery. For instance, in March 2024, Semarion Ltd, a spin-out company of the University of Cambridge, introduced their SemaCyte Multiplexing Platform that is designed for augmenting the speed and quality of data generation. The multiplexing platform was developed with the help of the company's microarray technology and is designed to provide flexibility and resource efficiency and a more systemized route for conducting cell assays.

North America Accounts for Significant Market Share

The growth of the market in North America is supported by the rising cases of chronic and infectious diseases in the region, increasing investments by healthcare and biotechnology companies towards the development of advanced technologies, a high rate of acceptance of novel technological solutions, and rapid expansion of the healthcare sector. Furthermore, the strong presence of biotechnology companies in the region, coupled with increasing investments to promote the development of novel solutions, is also supporting the market's expansion in North America. For instance, in June 2024, RareCyte, Inc., one of the leading life science companies, announced the completion of funding of USD 20 million from existing and new investors. This funding is expected to support the company in boosting the expansion of the Orion Spatial Biology platform, which includes commercializing software applications, multiplex assays, and reagent products.

Protein Multiplex Assays Expected to Witness Significant Growth

The segment's expansion is supported by the increasing investments and emphasis on proteomics studies for clinical diagnosis and biomarker research. In October 2023, Thermo Fisher Scientific Inc. acquired Olink for USD 3.1 billion to expand its presence in the proteomics sector. The latter provides a platform of products and services that are proteomics-focused; their proximity extension assay (PEA) technology has been designed to enable high throughput. Such acquisitions underscore the impact that the field of proteomics has had on advancements in precision medicine and life science research, among others. The rising investments towards the research and development activities by various pharmaceutical companies and research institutions towards protein multiplex assays also bolster the growth of the segment. These assays also provide a wide range of advantages regarding the sample requirements and the amount of data generated, along with time and cost efficiency.

Future Market Scenario (2024-2031F)

According to the global multiplex assays market analysis, the rising cancer cases are expected to provide lucrative growth opportunities to the market. The American Cancer Society estimates that the number of cases of cancer will reach 35 million by 2050. This rise is anticipated to propel the market demand as it aids in enhancing the understanding of the role of various immune regulators in cancer and quantitative profiling of co-stimulating and co-inhibitory immune checkpoint proteins. Additionally, the rising cases of infectious diseases are also supporting the expansion of the market as multiplex testing supports the detection of multiple loci or analytes from several pathogens in a single well. Furthermore, the growth of the market is also supported by the rising research and development activities by various biotechnology companies and research institutions across the globe. For instance, the Oslo University Hospital is conducting an interventional study that is expected to conclude in December 2025 to assess the clinical utility of circulating tumor DNA assays in patients that have advanced malignancies. The project aims to evaluate the extent to which the circulating tumor DNA assays are relevant in clinical decision-making.

Key Players Landscape and Outlook

The increasing efforts of the key players of the market towards the development of advanced solutions is one of the major factors bolstering the global multiplex assays market growth. In April 2024, Bio-Rad Laboratories, Inc. announced the launch of the ddPLEX ESR1 mutation detection kit, an ultrasensitive multiplexed digital PCR assay that enables quantification, discrimination, and detection of seven ESR1 mutations and allows customers to achieve multiplexing and sensitivity, without compromising throughput. Such developments showcase the dedication of the key market players to provide new technologies to cancer researchers that will enable everything that boosts improvement in patient monitoring.

The growth of the market is also supported by the increasing introduction of novel products and technologies by the key players in the market in various geographical locations. In February 2023, Thermo Fisher Scientific Inc. launched PCR kits for detecting infectious diseases in India. The Applied Biosystems TaqPath PCR kits have been clinically and analytically validated for use in diagnosis and disease screening, identification of risk factors that are genetic, and monitoring of disease progression and therapeutic responses in patients. Such efforts showcase the dedication of the company for providing new workflows and innovation to enhance diagnostic solutions and advance research of infectious diseases.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Multiplex Assays Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product
    • 4.2.1. Instruments and Accessories
    • 4.2.2. Reagents and Consumables
    • 4.2.3. Software and Services
  • 4.3. By Type
    • 4.3.1. Nucleic Acid Multiplex Assays
      • 4.3.1.1. Planar Nucleic Acid Assays
      • 4.3.1.2. Bead-based Nucleic Acid Multiplex Assays
      • 4.3.1.3. Others
    • 4.3.2. Protein Multiplex Assays
      • 4.3.2.1. Planar Protein Assays
      • 4.3.2.2. Bead-based Protein Assays
      • 4.3.2.3. Others
    • 4.3.3. Cell-based Multiplex Assays
  • 4.4. By Technology
    • 4.4.1. Protein Microarray
    • 4.4.2. Polymerase Chain Reaction
    • 4.4.3. Fluorescence Detection
    • 4.4.4. Flow Cytometry
    • 4.4.5. Multiplex Real-Time PCR
    • 4.4.6. Luminescence
    • 4.4.7. Others
  • 4.5. By Application
    • 4.5.1. Clinical Diagnostics
      • 4.5.1.1. Cancer
      • 4.5.1.2. Infectious Diseases
      • 4.5.1.3. Autoimmune Diseases
      • 4.5.1.4. Metabolism and Endocrinology Disorders
      • 4.5.1.5. Nervous System Disorders
      • 4.5.1.6. Cardiovascular Diseases
      • 4.5.1.7. Others
    • 4.5.2. Research and Development
      • 4.5.2.1. Biomarker Discovery and Validation
      • 4.5.2.2. Drug Discovery and Development
  • 4.6. By End-user
    • 4.6.1. Pharmaceutical and Biotechnology Companies
    • 4.6.2. Hospitals
    • 4.6.3. Academic and Research Institutes
    • 4.6.4. Clinical Laboratories
    • 4.6.5. Others
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. South America
    • 4.7.3. Europe
    • 4.7.4. Asia-Pacific
    • 4.7.5. Middle East and Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Multiplex Assays Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product
      • 5.1.2.1. Instruments and Accessories
      • 5.1.2.2. Reagents and Consumables
      • 5.1.2.3. Software and Services
    • 5.1.3. By Type
      • 5.1.3.1. Nucleic Acid Multiplex Assays
        • 5.1.3.1.1. Planar Nucleic Acid Assays
        • 5.1.3.1.2. Bead-based Nucleic Acid Multiplex Assays
        • 5.1.3.1.3. Others
      • 5.1.3.2. Protein Multiplex Assays
        • 5.1.3.2.1. Planar Protein Assays
        • 5.1.3.2.2. Bead-based Protein Assays
        • 5.1.3.2.3. Others
      • 5.1.3.3. Cell-based Multiplex Assays
    • 5.1.4. By Technology
      • 5.1.4.1. Protein Microarray
      • 5.1.4.2. Polymerase Chain Reaction
      • 5.1.4.3. Fluorescence Detection
      • 5.1.4.4. Flow Cytometry
      • 5.1.4.5. Multiplex Real-Time PCR
      • 5.1.4.6. Luminescence
      • 5.1.4.7. Others
    • 5.1.5. By Application
      • 5.1.5.1. Clinical Diagnostics
        • 5.1.5.1.1. Cancer
        • 5.1.5.1.2. Infectious Diseases
        • 5.1.5.1.3. Autoimmune Diseases
        • 5.1.5.1.4. Metabolism and Endocrinology Disorders
        • 5.1.5.1.5. Nervous System Disorders
        • 5.1.5.1.6. Cardiovascular Diseases
        • 5.1.5.1.7. Others
      • 5.1.5.2. Research and Development
        • 5.1.5.2.1. Biomarker Discovery and Validation
        • 5.1.5.2.2. Drug Discovery and Development
    • 5.1.6. By End-user
      • 5.1.6.1. Pharmaceutical and Biotechnology Companies
      • 5.1.6.2. Hospitals
      • 5.1.6.3. Academic and Research Institutes
      • 5.1.6.4. Clinical Laboratories
      • 5.1.6.5. Others
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
        • 5.1.7.1.1. By Value
        • 5.1.7.1.2. By Volume
      • 5.1.7.2. By Product
        • 5.1.7.2.1. Instruments and Accessories
        • 5.1.7.2.2. Reagents and Consumables
        • 5.1.7.2.3. Software and Services
      • 5.1.7.3. By Type
        • 5.1.7.3.1. Nucleic Acid Multiplex Assays
          • 5.1.7.3.1.1. Planar Nucleic Acid Assays
          • 5.1.7.3.1.2. Bead-based Nucleic Acid Multiplex Assays
          • 5.1.7.3.1.3. Others
        • 5.1.7.3.2. Protein Multiplex Assays
          • 5.1.7.3.2.1. Planar Protein Assays
          • 5.1.7.3.2.2. Bead-based Protein Assays
          • 5.1.7.3.2.3. Others
        • 5.1.7.3.3. Cell-based Multiplex Assays
      • 5.1.7.4. By Technology
        • 5.1.7.4.1. Protein Microarray
        • 5.1.7.4.2. Polymerase Chain Reaction
        • 5.1.7.4.3. Fluorescence Detection
        • 5.1.7.4.4. Flow Cytometry
        • 5.1.7.4.5. Multiplex Real-Time PCR
        • 5.1.7.4.6. Luminescence
        • 5.1.7.4.7. Others
      • 5.1.7.5. By Application
        • 5.1.7.5.1. Clinical Diagnostics
          • 5.1.7.5.1.1. Cancer
          • 5.1.7.5.1.2. Infectious Diseases
          • 5.1.7.5.1.3. Autoimmune Diseases
          • 5.1.7.5.1.4. Metabolism and Endocrinology Disorders
          • 5.1.7.5.1.5. Nervous System Disorders
          • 5.1.7.5.1.6. Cardiovascular Diseases
          • 5.1.7.5.1.7. Others
        • 5.1.7.5.2. Research and Development
          • 5.1.7.5.2.1. Biomarker Discovery and Validation
          • 5.1.7.5.2.2. Drug Discovery and Development
      • 5.1.7.6. By End-user
        • 5.1.7.6.1. Pharmaceutical and Biotechnology Companies
        • 5.1.7.6.2. Hospitals
        • 5.1.7.6.3. Academic and Research Institutes
        • 5.1.7.6.4. Clinical Laboratories
        • 5.1.7.6.5. Others
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Type
  • 6.3. By Technology
  • 6.4. By Application
  • 6.5. By End-user
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrants
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Illumina, Inc.
  • 13.3. Bio-Rad Laboratories, Inc.
  • 13.4. QIAGEN N.V.
  • 13.5. Becton, Dickinson and Company
  • 13.6. DiaSorin S.p.A.
  • 13.7. Seegene, Inc.
  • 13.8. Abcam Limited
  • 13.9. MESO SCALE DIAGNOSTICS, LLC
  • 13.10. Merck KGaA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 5. Global Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 6. Global Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Multiplex Assays Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 11. North America Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 12. North America Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 13. North America Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 14. North America Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 15. North America Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Multiplex Assays Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 19. United States Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 20. United States Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 21. United States Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 22. United States Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 23. United States Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 26. Canada Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 27. Canada Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 28. Canada Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 29. Canada Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 33. Mexico Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 34. Mexico Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 35. Mexico Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 36. Mexico Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 40. Europe Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 41. Europe Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 42. Europe Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 43. Europe Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Multiplex Assays Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. Germany Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 49. Germany Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 50. Germany Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 51. Germany Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 55. France Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 56. France Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 57. France Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 58. France Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 59. France Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 62. Italy Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 63. Italy Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 64. Italy Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 65. Italy Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 69. United Kingdom Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 70. United Kingdom Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 71. United Kingdom Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 72. United Kingdom Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 76. Russia Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 77. Russia Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 78. Russia Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 79. Russia Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 80. Russia Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 81. Netherlands Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 83. Netherlands Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 84. Netherlands Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 85. Netherlands Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 86. Netherlands Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 87. Netherlands Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 88. Spain Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Spain Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 91. Spain Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 92. Spain Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 93. Spain Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 94. Spain Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 95. Turkey Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 97. Turkey Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 98. Turkey Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 99. Turkey Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 100. Turkey Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 101. Turkey Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 102. Poland Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 104. Poland Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 105. Poland Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 106. Poland Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 107. Poland Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 108. Poland Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 109. South America Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 111. South America Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 112. South America Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 113. South America Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 114. South America Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 115. South America Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 116. South America Multiplex Assays Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 119. Brazil Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 120. Brazil Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 121. Brazil Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 122. Brazil Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 123. Brazil Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 124. Argentina Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 126. Argentina Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 127. Argentina Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 128. Argentina Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 129. Argentina Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 130. Argentina Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 131. Asia-Pacific Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 133. Asia-Pacific Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 134. Asia-Pacific Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 135. Asia-Pacific Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 136. Asia-Pacific Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 137. Asia- Pacific Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 138. Asia-Pacific Multiplex Assays Market Share (%), By Country, 2017-2031F
  • Figure 139. India Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 141. India Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 142. India Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 143. India Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 144. India Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 145. India Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 146. China Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 148. China Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 149. China Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 150. China Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 151. China Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 152. China Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 153. Japan Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 155. Japan Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 156. Japan Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 157. Japan Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 158. Japan Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 159. Japan Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 160. Australia Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 162. Australia Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 163. Australia Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 164. Australia Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 165. Australia Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 166. Australia Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 167. Vietnam Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 169. Vietnam Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 170. Vietnam Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 171. Vietnam Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 172. Vietnam Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 173. Vietnam Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 174. South Korea Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 176. South Korea Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 177. South Korea Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 178. South Korea Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 179. South Korea Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 180. South Korea Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 181. Indonesia Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. Indonesia Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 184. Indonesia Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 185. Indonesia Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 186. Indonesia Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 187. Indonesia Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 188. Philippines Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 190. Philippines Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 191. Philippines Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 192. Philippines Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 193. Philippines Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 194. Philippines Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 195. Middle East & Africa Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 197. Middle East & Africa Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 198. Middle East & Africa Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 199. Middle East & Africa Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 200. Middle East & Africa Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 201. Middle East & Africa Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 202. Middle East & Africa Multiplex Assays Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 205. Saudi Arabia Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 206. Saudi Arabia Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 207. Saudi Arabia Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 208. Saudi Arabia Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 209. Saudi Arabia Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 210. UAE Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 212. UAE Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 213. UAE Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 214. UAE Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 215. UAE Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 216. UAE Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 217. South Africa Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
  • Figure 219. South Africa Multiplex Assays Market Share (%), By Product, 2017-2031F
  • Figure 220. South Africa Multiplex Assays Market Share (%), By Type, 2017-2031F
  • Figure 221. South Africa Multiplex Assays Market Share (%), By Technology, 2017-2031F
  • Figure 222. South Africa Multiplex Assays Market Share (%), By Application, 2017-2031F
  • Figure 223. South Africa Multiplex Assays Market Share (%), By End-user, 2017-2031F
  • Figure 224. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023